2021.07.15 Press release

--To the press -

FRONTEO Starts Demonstration Test of Fall Prediction AI System for Medical Care Service and Long-term Care Facilities of Gakken Group

FRONTEO Inc.
Masahiro Morimoto, President and CEO
東京 都 港区 港 南 2-12-23
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) and Medical Care Service Co., Ltd. (Headquarters: Saitama City, Saitama Prefecture, President: Norio Yamamoto, hereafter MCS) , We will start a verification test for the development of a fall prediction AI system based on the care records recorded at the care facility.

 

 MCS is a group company of Gakken Holdings Co., Ltd. (Headquarters: Shinagawa-ku, Tokyo, President: Hiroaki Miyahara, hereinafter Gakken HD). FRONTEO and Gakken HD entered into a business and capital alliance in November 2020.1), This verification test is conducted as part of this. MCS operates 280 group homes for the elderly with dementia, paid elderly homes with long-term care, and small-scale multifunctional home care.In addition, we are promoting DX (digital transformation) in the field of long-term care, and by utilizing ICT such as long-term care recording systems and long-term care robots in the facilities we operate, we aim to improve the productivity of long-term care sites and the quality of care. We are incorporating technology into long-term care.

 

 Falling / falling of the elderly may lead to death as well as the need for long-term care / bedridden condition and the progression of dementia.Furthermore, in long-term care facilities, it is extremely important to prevent falls because the occurrence of falls may affect the relationship of trust between the facility and the resident's family.On the other hand, in facilities that are "places of living," excessive fall / fall prevention can lead to behavioral restrictions, and ensuring safety and maintaining the freedom of behavior and QOL of the elderly are a major factor in nursing care. This is one of the challenges.

 

 Based on this situation, FRONTEO will work with MCS to develop new software that will solve these issues by utilizing FRONTEO's unique AI technology and experience in the medical field.FRONTEO's fall prediction AI system "Coroban", which has already been launched, predicts the risk of falls of inpatients based on nursing records recorded in electronic medical records at medical institutions. We will verify the prediction accuracy of the fall risk of facility residents by targeting nursing care records of group homes operated by.

 

 If this test demonstrates that FRONTEO's fall prediction AI system can be widely used not only in medical institutions but also in nursing care facilities, it will prevent falls in the elderly, improve the QOL of the elderly, and reduce the burden on nursing care sites. We believe that we can contribute to. FRONTEO will continue to strive to provide solutions for solving problems in medical and long-term care sites through research and development of AI systems.

 

 The impact of this matter alone on FRONTEO's business results for the current fiscal year is minor, but we will promptly notify you if there are any matters to be disclosed.

 

1) https://ssl4.eir-parts.net/doc/2158/tdnet/1906975/00.pdf

 


■ About Medical Care Service Co., Ltd. (MCS) URL:https://www.mcsg.co.jp/
Founded in 1999 in Saitama City, Saitama Prefecture.We develop a variety of long-term care services with strengths in dementia care, such as the group home "Ai no Ie" for the elderly with dementia and the paid nursing homes "Ensemble" and "Faminew" with long-term care.The number of operating rooms in group homes is the highest in Japan.
In addition, we are promoting businesses such as pay nursing home management and development consulting overseas, including China, with the aim of transforming all social environments surrounding dementia.

■ About Coroban URL:https://lifescience.fronteo.com/aidevice/coroban/
Coroban is a fall prediction AI system developed by FRONTEO in collaboration with Eisai Inc. FRONTEO's natural language analysis AI "Concept Encoder" reads electronic medical records and evaluates the risk of falls from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall risk evaluation sheet without increasing the burden on medical staff.Recommended by the Japan Fall Prevention Society.Patent registration number: Patent No. 6652986.

■ About Concept Encoder
URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge" , Drug discovery support, dementia diagnosis support, financial / human resources / sales support, etc., contributing to solving various corporate issues. Listed on TSE Mothers on June 2014, 2007. January 6 Obtained a first-class medical device manufacturing and sales license (permit number: 26B2021X1).The capital is 13 thousand yen (as of March 1, 10350).

* FRONTEO, Coroban, conceptencoder, and KIBIT are registered trademarks of FRONTEO in Japan.

<Contact information for the press>

Public Relations Officer, FRONTEO Inc. Segawa

E-mail: pr_contact@fronteo.com

 

<Inquiries about Life Science AI Business>

FRONTEO Inc. Life Science AI Business Headquarters

https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x